Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

This study has been completed.

Study NCT00157482 Information provided by Mario Negri Institute for Pharmacological Research

First Received: September 8, 2005 Last Updated: February 12, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given

No publications provided by Mario Negri Institute for Pharmacological Research

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ruggenenti P, Cattaneo D, Rota S, Iliev I, Parvanova A, Diadei O, Ene-Iordache B, Ferrari S, Bossi AC, Trevisan R, Belviso A, Remuzzi G; Ezetimibe and Simvastatin in Dyslipidemia of Diabetes (ESD) Study Group. Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial. Diabetes Care. 2010 Sep;33(9):1954-6. Epub 2010 Jun 21.